Corsello A, Milani GP, Picca M, Buzzetti R, Carrozzo R, Gambino M, Chiaffoni G, Marchisio P, Mameli C. Recurrent upper respiratory tract infections in early childhood: a newly defined clinical condition. Italian Journal of Pediatrics, 2024;:-
Corsello A, Milani GP, Picca M, Buzzetti R, Carrozzo R, Gambino M, Chiaffoni G, Marchisio P, Mameli C. Recurrent upper respiratory tract infections in early childhood: a newly defined clinical condition. Italian Journal of Pediatrics, 2024;:-
Coordinatore e docente Percorso Formativo "Esperti Insieme" per volontari Fondazione Fibrosi Cistica
Docenza al Corso “Approfondimenti statistici nell’utilizzo dei dati di letteratura” presso H Papa Giovanni XXIII - BG
Docenza in Statistica ed Epidemiologia presso il Master per Infermieri di Comunità - BS Univ Cattolica
Tosco A, Poli P, Casale A, De Gregorio F, Sepe A, Buonpensiero P, Di Pasqua A, Castaldo A, Cimbalo C, Buzzetti R, Raia V, Berlucchi M, Timpano S, Badolato R, Padoan R, Orlando C. The Role of Bronchoscopy in the Management of Children With Cystic Fibrosis. J Bronchol Intervent Pulmonol, 2023;30:258-267
Picca M, Romeo Carrozzo R, Milani GP, Corsello A, Macchi M, Buzzetti R, Marchisio P, Chiara Mameli C. Leading reasons for antibiotic prescriptions in pediatric respiratory infections: influence of fever in a primary care setting. Italian Journal of Pediatrics, 2023;49(1):131-
Lucca F, Buzzetti R, Di Leonardo A. Conoscere ed interpretare le differenze – INHALED MRNA THERAPY FOR TREATMENT OF CYSTIC FIBROSIS: INTERIM RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1/2 CLINICAL STUDY. Orizzonti FC, 2023;20 (3):27-31
Lucca F, Buzzetti R, Braggion C. Conoscere ed interpretare le differenze – EFFECT OF AIRWAY CLEARANCE THERAPIES ON MUCOCILIARY CLEARANCE IN ADULTS WITH CYSTIC FIBROSIS: A RANDOMIZED CONTROLLED TRIAL. Orizzonti FC, 2023;20 (3):31-34
Buzzetti R, Cirilli N, Raia V, Salvatore D, Daniele A. DAL CYSTIC FIBROSIS DATABASE (CFDB): QUANDO UNA COPPIA E’ A RISCHIO DI AVERE UN FIGLIO AFFETTO DA FIBROSI CISTICA. Orizzonti FC, 2023;20 (3):35-37
Majo F, Buzzetti R, Mori G, Percudani R. Conoscere ed interpretare le differenze – DISCONTINUATION VERSUS CONTINUATION OF HYPERTONIC SALINE OR DORNASE ALFA IN MODULATOR TREATED PEOPLE WITH CYSTIC FIBROSIS (SIMPLIFY): RESULTS FROM TWO PARALLEL, MULTICENTRE, OPENLABEL, RANDOMIZED, CONTROLLED, NON-INFERIORITY TRIALS. Orizzonti FC, 2023;20 (1):24-28